InMed Pharmaceuticals Inc. (INM)

InMed Pharmaceuticals Statistics

Total Valuation

INM has a market cap or net worth of $4.82 million. The enterprise value is -$3.91 million.

Market Cap	4.82M
Enterprise Value	-3.91M

Important Dates

The last earnings date was Thursday, November 6, 2025, after market close.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

INM has 3.95 million shares outstanding. The number of shares has increased by 699.74% in one year.

Current Share Class	2.80M
Shares Outstanding	3.95M
Shares Change (YoY)	+699.74%
Shares Change (QoQ)	+165.01%
Owned by Insiders (%)	0.12%
Owned by Institutions (%)	5.03%
Float	2.80M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.99
Forward PS	n/a
PB Ratio	0.41
P/TBV Ratio	0.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.95, with a Debt / Equity ratio of 0.06.

Current Ratio	6.95
Quick Ratio	6.25
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -82.17% and return on invested capital (ROIC) is -45.70%.

Return on Equity (ROE)	-82.17%
Return on Assets (ROA)	-41.59%
Return on Invested Capital (ROIC)	-45.70%
Return on Capital Employed (ROCE)	-67.15%
Revenue Per Employee	$369,086
Profits Per Employee	-$631,628
Employee Count	13
Asset Turnover	0.40
Inventory Turnover	3.01

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -73.82% in the last 52 weeks. The beta is 0.29, so INM's price volatility has been lower than the market average.

Beta (5Y)	0.29
52-Week Price Change	-73.82%
50-Day Moving Average	1.98
200-Day Moving Average	2.50
Relative Strength Index (RSI)	24.21
Average Volume (20 Days)	824,211

Short Selling Information

The latest short interest is 3,318, so 0.08% of the outstanding shares have been sold short.

Short Interest	3,318
Short Previous Month	6,395
Short % of Shares Out	0.08%
Short % of Float	0.12%
Short Ratio (days to cover)	0.03

Income Statement

In the last 12 months, INM had revenue of $4.80 million and -$8.21 million in losses. Loss per share was -$2.08.

Revenue	4.80M
Gross Profit	1.62M
Operating Income	-7.93M
Pretax Income	-8.21M
Net Income	-8.21M
EBITDA	-7.72M
EBIT	-7.93M
Loss Per Share	-$2.08

Balance Sheet

The company has $9.37 million in cash and $640,243 in debt, giving a net cash position of $8.73 million or $2.21 per share.

Cash & Cash Equivalents	9.37M
Total Debt	640,243
Net Cash	8.73M
Net Cash Per Share	$2.21
Equity (Book Value)	11.59M
Book Value Per Share	2.93
Working Capital	9.24M

Cash Flow

Operating Cash Flow	-7.55M
Capital Expenditures	n/a
Free Cash Flow	-7.55M
FCF Per Share	-$1.91

Margins

Gross margin is 33.69%, with operating and profit margins of -165.22% and -171.13%.

Gross Margin	33.69%
Operating Margin	-165.22%
Pretax Margin	-171.13%
Profit Margin	-171.13%
EBITDA Margin	-160.81%
EBIT Margin	-165.22%
FCF Margin	n/a

Dividends & Yields

INM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-699.74%
Shareholder Yield	-699.74%
Earnings Yield	-170.20%
FCF Yield	-156.44%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 14, 2024. It was a reverse split with a ratio of 1:20.

Last Split Date	Nov 14, 2024
Split Type	Reverse
Split Ratio	1:20

Scores

INM has an Altman Z-Score of -12.04 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-12.04
Piotroski F-Score	3